These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
152 related items for PubMed ID: 8496621
1. Cytolytic antibodies to melanocytes in vitiligo. Cui J, Arita Y, Bystryn JC. J Invest Dermatol; 1993 Jun; 100(6):812-5. PubMed ID: 8496621 [Abstract] [Full Text] [Related]
2. Evidence for immunologic mechanisms in human vitiligo: patients' sera induce damage to human melanocytes in vitro by complement-mediated damage and antibody-dependent cellular cytotoxicity. Norris DA, Kissinger RM, Naughton GM, Bystryn JC. J Invest Dermatol; 1988 Jun; 90(6):783-9. PubMed ID: 3373009 [Abstract] [Full Text] [Related]
3. Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo. Harning R, Cui J, Bystryn JC. J Invest Dermatol; 1991 Dec; 97(6):1078-80. PubMed ID: 1748818 [Abstract] [Full Text] [Related]
4. Detection of antibodies to melanocytes in vitiligo by specific immunoprecipitation. Naughton GK, Eisinger M, Bystryn JC. J Invest Dermatol; 1983 Dec; 81(6):540-2. PubMed ID: 6196421 [Abstract] [Full Text] [Related]
5. IgG anti-melanocyte antibodies purified from patients with active vitiligo induce HLA-DR and intercellular adhesion molecule-1 expression and an increase in interleukin-8 release by melanocytes. Li YL, Yu CL, Yu HS. J Invest Dermatol; 2000 Dec; 115(6):969-73. PubMed ID: 11121127 [Abstract] [Full Text] [Related]
6. Detection of antibodies to melanocytes in vitiligo by western immunoblotting. Hann SK, Shin HK, Park SH, Reynolds SR, Bystryn JC. Yonsei Med J; 1996 Dec; 37(6):365-70. PubMed ID: 9048487 [Abstract] [Full Text] [Related]
7. Melanoma and vitiligo are associated with antibody responses to similar antigens on pigment cells. Cui J, Bystryn JC. Arch Dermatol; 1995 Mar; 131(3):314-8. PubMed ID: 7887661 [Abstract] [Full Text] [Related]
8. Identification of autoantibody to melanocytes and characterization of vitiligo antigen in vitiligo patients. Park YK, Kim NS, Hann SK, Im S. J Dermatol Sci; 1996 Feb; 11(2):111-20. PubMed ID: 8869031 [Abstract] [Full Text] [Related]
9. Serum Antibodies to Melanocytes in Patients With Vitiligo Are Predictors of Disease Progression. Jimenez-Brito G, Garza-de-La-Peña E, Pérez-Romano B, Ruiz-Argüelles A. Skinmed; 2016 Feb; 14(1):17-21. PubMed ID: 27072723 [Abstract] [Full Text] [Related]